AMP-activated protein kinase as a drug target

被引:343
作者
Hardie, D. Grahame [1 ]
机构
[1] Univ Dundee, Div Mol Physiol, Dundee DD1 5EH, Scotland
基金
英国惠康基金;
关键词
metformin; biguanides; thiazolidinediones; obesity; diabetes;
D O I
10.1146/annurev.pharmtox.47.120505.105304
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The AMP-activated protein kinase (AMPK) system is a regulator of energy balance at both the cellular and whole-body levels that, once activated by low energy status, effects a switch from ATP-consuming anabolic pathways to ATP-producing catabolic pathways. It now appears to be the major target for two existing classes of drug used to treat type 2 diabetes, i.e., the biguanides and thiazolidinediones. However, in both cases these activate AMPK indirectly, and an interesting question concerns whether a drug that directly activated AMPK would retain the therapeutic benefits of the existing drugs while eliminating unwanted side effects. AMPK activators also now have potential as anticancer drugs.
引用
收藏
页码:185 / 210
页数:26
相关论文
共 164 条
  • [1] The subcellular localization of acetyl-CoA carboxylase 2
    Abu-Elheiga, L
    Brinkley, WR
    Zhong, L
    Chirala, SS
    Woldegiorgis, G
    Wakil, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1444 - 1449
  • [2] Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
    Abu-Elheiga, L
    Matzuk, MM
    Abo-Hashema, KAH
    Wakil, SJ
    [J]. SCIENCE, 2001, 291 (5513) : 2613 - 2616
  • [3] Components of a calmodulin-dependent protein kinase cascade -: Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase β
    Anderson, KA
    Means, RL
    Huang, QH
    Kemp, BE
    Goldstein, EG
    Selbert, MA
    Edelman, AM
    Fremeau, RT
    Means, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 31880 - 31889
  • [4] AMP-activated protein kinase plays a role in the control of food intake
    Andersson, U
    Filipsson, K
    Abbott, CR
    Woods, A
    Smith, K
    Bloom, SR
    Carling, D
    Small, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12005 - 12008
  • [5] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
    Arad, M
    Benson, DW
    Perez-Atayde, AR
    McKenna, WJ
    Sparks, EA
    Kanter, RJ
    McGarry, K
    Seidman, JG
    Seidman, CE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) : 357 - 362
  • [6] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [7] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [8] EFFECT OF METFORMIN ON GLUCOSE-METABOLISM IN THE SPLANCHNIC BED
    BAILEY, CJ
    WILCOCK, C
    DAY, C
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) : 1009 - 1013
  • [9] Regulation of fasted blood glucose by resistin
    Banerjee, RR
    Rangwala, SM
    Shapiro, JS
    Rich, AS
    Rhoades, B
    Qi, Y
    Wang, J
    Rajala, MW
    Pocai, A
    Scherer, PE
    Steppan, CM
    Ahima, RS
    Obici, S
    Rossetti, L
    Lazar, MA
    [J]. SCIENCE, 2004, 303 (5661) : 1195 - 1198
  • [10] Barnes K, 2002, J CELL SCI, V115, P2433